Showing results (11-20 of 169) with videos related to
Sort By:
Pageof 17
Neurocritical Care|December 7, 2007
Preclinical models of intracerebral hemorrhage: a translational perspectiveMichael Lucas James, David S Warner, Daniel T LaskowitzJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 3, 2009
Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humansMichael L James, Robert Blessing, Ellen Bennett, et al.Oligonucleotides|December 15, 2010
A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhageCharlene M Blake, Haichen Wang, Daniel T Laskowitz, et al.Chest|January 18, 2021
Multiorgan Dysfunction After Severe Traumatic Brain Injury: Epidemiology, Mechanisms, and Clinical ManagementVijay Krishnamoorthy, Jordan M Komisarow, Daniel T Laskowitz, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 15, 2013
A blood-based biomarker panel to detect acute strokeRicha Sharma, Stephanie Macy, Kara Richardson, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 23, 2020
Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary InjuryMichael L James, Jordan M Komisarow, Haichen Wang, et al.JAMA Neurology|August 12, 2014
Translational research in acute central nervous system injury: lessons learned and the futureDavid S Warner, Michael L James, Daniel T Laskowitz, et al.Academic Medicine : Journal of the Association of American Medical Colleges|February 26, 2010
Engaging students in dedicated research and scholarship during medical school: the long-term experiences at Duke and StanfordDaniel T Laskowitz, Robert P Drucker, Julie Parsonnet, et al.Plos One|October 19, 2023
Cortical spheroid on perfusable microvascular network in a microfluidic deviceTeal Russell, Qassim Dirar, Yan Li, et al.Clinical Pharmacology in Drug Development|January 16, 2023
Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor InhibitorRobert Zaczek, Stephen F Traynelis, Ray Dingledine, et al.Pageof 17